Selected article for: "BIS group and MONT group"

Author: Kim, Chang-Keun; Callaway, Zak; Park, Jin-Sung; Nishimori, Hisashi; Ogino, Tikatoshi; Nagao, Mizuho; Fujisawa, Takao
Title: Montelukast Reduces Serum Levels of Eosinophil-Derived Neurotoxin in Preschool Asthma
  • Document date: 2018_8_30
  • ID: uzge50xu_25
    Snippet: There was no significant change in sEDN in the BIS group (Fig. 4A) , but there was a significant decrease found in the MONT group (P < 0.000) (Fig. 4B) . When the OBS group was divided into those with low EDN (< 53 ng/mL) (Fig. 4C) and those with high EDN (> 53 ng/mL) (Fig. 4D) , only patients with high EDN exhibited a significant decrease due to MONT treatment (P = 0.023), regardless of HDM sensitization......
    Document: There was no significant change in sEDN in the BIS group (Fig. 4A) , but there was a significant decrease found in the MONT group (P < 0.000) (Fig. 4B) . When the OBS group was divided into those with low EDN (< 53 ng/mL) (Fig. 4C) and those with high EDN (> 53 ng/mL) (Fig. 4D) , only patients with high EDN exhibited a significant decrease due to MONT treatment (P = 0.023), regardless of HDM sensitization.

    Search related documents:
    Co phrase search for related documents
    • BIS group and MONT treatment: 1, 2
    • BIS group and OBS group: 1, 2, 3
    • BIS group and sEDN significant change: 1
    • BIS group and significant change: 1, 2
    • BIS group and significant decrease: 1, 2, 3
    • mont group and OBS group: 1, 2, 3, 4, 5
    • mont group and sEDN significant change: 1
    • mont group and significant change: 1
    • mont group and significant decrease: 1, 2, 3
    • MONT treatment and OBS group: 1, 2
    • MONT treatment and sEDN significant change: 1
    • MONT treatment and significant change: 1
    • MONT treatment and significant decrease: 1
    • OBS group and sEDN significant change: 1
    • OBS group and significant change: 1
    • OBS group and significant decrease: 1, 2
    • sEDN significant change and significant decrease: 1